Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

被引:9
|
作者
Ninomiya, Toshifumi [1 ,2 ]
Otsubo, Kohei [1 ]
Hoshino, Teppei [3 ]
Shimokawa, Mototsugu [4 ]
Nakazawa, Megumi [2 ]
Sato, Yoriko [2 ]
Mikumo, Hironori [2 ]
Kawakami, Satoru [2 ,5 ]
Mizusaki, Shun [1 ,2 ]
Mori, Yusuke [3 ]
Arimura, Hidenobu [1 ]
Tsuchiya-Kawano, Yuko [1 ]
Inoue, Koji [1 ]
Uchida, Yujiro [2 ]
Nakanishi, Yoichi [6 ]
机构
[1] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Gen Internal Med, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan
[3] Kitakyushu City Yahata Hosp, Dept Internal Med, Yahatahigashi Ku, 2-6-2 Ogura, Kitakyushu, Fukuoka 8058534, Japan
[4] Yamaguchi Univ, Dept Biostat, Grad Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan
[5] JCHO Kyushu Hosp, Dept Resp Med, Yahatanishi Ku, 1-8-1 Kishinoura, Kitakyushu, Fukuoka 8068501, Japan
[6] Kitakyushu City Hosp Org, Kokurakita Ku, 1-35 Furusenba Machi, Kitakyushu, Fukuoka 8020082, Japan
关键词
COVID-19; Risk factors; Disease progression;
D O I
10.1186/s12879-021-06574-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms. Methods All 302 consecutive patients who were admitted to our institutions and diagnosed with COVID-19 between March and December 2020 were retrospectively assessed. Ultimately, 210 adult patients exhibiting no or mild symptoms on admission were included in the analysis. They were categorized into the stable (no oxygen needed) and worsened (oxygen needed) groups, and their characteristics and laboratory data were compared. Results Among 210 patients, 49 progressed to a severe disease stage, whereas 161 did not. The mean patient age was 52.14 years, and 126 (60.0%) patients were male. The mean body mass index (BMI) was 23.0 kg/m(2), and 71 patients were overweight (BMI >= 25 kg/m(2)). Multivariate logistic analysis showed that old age, overweight, diabetes mellitus (DM), and high serum ferritin levels were independent risk factors for disease progression. Conclusions Clinicians should closely observe patients with COVID-19, especially those with risk factors such as old age, overweight, DM, and high serum ferritin levels, regardless of whether they have no or mild symptoms.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Risk Factors Associated with Severe Disease and Intensive Care Unit Admission of Pregnant Patients with COVID-19 Infection-A Retrospective Study
    Adam, Ana-Maria
    Vasilache, Ingrid-Andrada
    Socolov, Demetra
    Cretu, Mariana Stuparu
    Georgescu, Costinela Valerica
    Vicoveanu, Petronela
    Mihalceanu, Elena
    Harabor, Anamaria
    Socolov, Razvan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [32] Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis
    Krzystanek, Ewa
    Jurczak, Agata
    Kocur, Kinga
    Jurkiewicz, Jakub
    Kaczmarczyk, Aleksandra
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (06)
  • [33] Prognostic nomogram on admission predicting progression for patients with nonsevere COVID-19
    Wang, Zhi
    Zhong, Bin-Yan
    Dai, Hui
    Xu, Qiu-Zhen
    Yang, Wei-Bin
    Zhang, Xin
    Xu, Chuan-Jun
    Shu, Jin-Er
    Shi, Biao
    Zeng, Chu-Hui
    Li, Cheng
    Ji, Jian-Song
    Li, Yong-Gang
    Teng, Gao-Jun
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 111 - 116
  • [34] Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19
    Jiaqi Huang
    Yu Xu
    Bin Wang
    Ying Xiang
    Na Wu
    Wenjing Zhang
    Tingting Xia
    Zhiquan Yuan
    Chengying Li
    Xiaoyue Jia
    Yifan Shan
    Menglei Chen
    Qi Li
    Li Bai
    Yafei Li
    BMC Pulmonary Medicine, 21
  • [35] Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19
    Huang, Jiaqi
    Xu, Yu
    Wang, Bin
    Xiang, Ying
    Wu, Na
    Zhang, Wenjing
    Xia, Tingting
    Yuan, Zhiquan
    Li, Chengying
    Jia, Xiaoyue
    Shan, Yifan
    Chen, Menglei
    Li, Qi
    Bai, Li
    Li, Yafei
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [36] Risk Factors for Weaning Failure in COVID-19 Patients
    Gerovasileiou, Effrosyni
    Menis, Apostolis-Alkiviadis
    Gavriilidis, George
    Magira, Eleni
    Temperikidis, Prodromos
    Papoti, Sofia
    Karavidas, Nikitas
    Spanos, Michael
    Zakynthinos, Epaminondas
    Makris, Demosthenes
    JOURNAL OF CRITICAL CARE MEDICINE, 2023, 9 (03) : 170 - 177
  • [37] Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study
    Kuo, Raymond N.
    Chen, Wanchi
    Shau, Wen-Yi
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [38] COVID-19 Symptoms at First Admission to Hospital
    Sahin, Erkan Melih
    Ocak, Ozgul
    Demiral, Cansu
    Donmez, Busra
    KONURALP TIP DERGISI, 2021, 13 (02): : 265 - 272
  • [39] Risk factors for poor outcome of patients with Coronavirus disease 2019 (COVID-19) in Albania
    Ramosaco, Ergys
    Kolovani, Entela
    Como, Najada
    Gjermeni, Nevila
    Shpata, Vjollca
    Kraja, Dhimiter
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (09): : 1236 - 1243
  • [40] The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients
    Liulin Wang
    Xiaobin Cheng
    Qiufen Dong
    Chenliang Zhou
    Yeming Wang
    Bin Song
    Weinan Li
    Min Wang
    Rui Qin
    Qi Long
    Juan Liu
    Jing Li
    Dan Li
    Gang Li
    Yuanming Ba
    BMC Infectious Diseases, 21